Search by Drug Name or NDC

    NDC 51759-0202-11 AJOVY 225 mg/1.5mL Details

    AJOVY 225 mg/1.5mL

    AJOVY is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is FREMANEZUMAB.

    Product Information

    NDC 51759-0202
    Product ID 51759-202_0ca1b7ee-c1d4-40cc-b545-34d9acf767ad
    Associated GPIs 6770203020D520
    GCN Sequence Number 080875
    GCN Sequence Number Description fremanezumab-vfrm AUTO INJCT 225 MG/1.5 SUBCUT
    HIC3 H3F
    HIC3 Description ANTIMIGRAINE PREPARATIONS
    GCN 47862
    HICL Sequence Number 045236
    HICL Sequence Number Description FREMANEZUMAB-VFRM
    Brand/Generic Brand
    Proprietary Name AJOVY
    Proprietary Name Suffix n/a
    Non-Proprietary Name fremanezumab-vfrm
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 225
    Active Ingredient Units mg/1.5mL
    Substance Name FREMANEZUMAB
    Labeler Name Teva Pharmaceuticals USA, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761089
    Listing Certified Through 2024-12-31

    Package

    NDC 51759-0202-11 (51759020211)

    NDC Package Code 51759-202-11
    Billing NDC 51759020211
    Package 1 CONTAINER in 1 CARTON (51759-202-11) / 1.5 mL in 1 CONTAINER
    Marketing Start Date 2020-03-29
    NDC Exclude Flag N
    Pricing Information N/A